The Senate Health, Education, Labor, and Pensions Committee (HELP) Tuesday passed an amendment that giving biologic manufactures 12 years of patent exclusivity from date of FDA approval.   The amendment was approved by a 16-7 vote, this change has now become “part of the larger healthcare overhaul."   The amendment was introduced by Senator … Continue reading Health Care Reform: Senate HELP adopts 12 Year Patent Exclusivity for Biologic Drugs